Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason A. Keyes currently holds 700 shares of Orexigen Therapeutics, Inc. (OREX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason A. Keyes has been a net seller of OREX stock. They have purchased $11.2K and sold $370.6K worth of shares.
Jason A. Keyes's most recent insider trade was on Aug 10, 2026, when they purchased 700 shares at $16.00 per share.
Jason A. Keyes serves as Executive at Orexigen Therapeutics, Inc. (OREX). They have executed 29 insider transactions totaling $381.8K over their tenure at the company.
Jason A. Keyes holds the position of Executive at Orexigen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Jason A. Keyes has shown a selling trading pattern, with $11.2K in total purchases and $370.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jason A. Keyes was on Sep 27, 2021, when they sold $53.9K worth of EQ shares. This transaction involved 8,000 shares at $6.74 per share.
Jason A. Keyes currently owns 700 shares of Orexigen Therapeutics, Inc. (OREX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason A. Keyes's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason A. Keyes has 29 Form 4 filings on record as an insider at Orexigen Therapeutics, Inc..
Set alerts for Jason A. Keyes and 40,000+ other insiders.